| University Community Health Center | |
|
2933 University Ave Riverside CA 92507-4243 | |
| (951) 224-8220 | |
| (951) 241-7290 |
| Full Name | University Community Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 2933 University Ave, Riverside, California |
| Authorized Official Name and Position | Lori Holeman (CEO) |
| Authorized Official Contact | 9515712300 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| University Community Health Center 22675 Alessandro Blvd Moreno Valley CA 92553-8551 Ph: (951) 571-2300 | University Community Health Center 2933 University Ave Riverside CA 92507-4243 Ph: (951) 224-8220 |
| NPI Number | 1205102068 |
|---|---|
| Provider Enumeration Date | 03/27/2012 |
| Last Update Date | 03/20/2019 |
| Medicare PECOS PAC ID | 7012824717 |
|---|---|
| Medicare Enrollment ID | O20130628000477 |
News Archive
Fine-scale climate model projections suggest the possibility that population centers in cool, highland regions of East Africa could be more vulnerable to malaria than previously thought, while population centers in hot, lowland areas could be less vulnerable, according to a team of researchers. The team applied a statistical technique to conventional, coarse-scale climate models to better predict malaria dynamics at local levels.
Clinical Care Options, a leader in education for healthcare professionals, will provide official online scientific analysis of the XVIII International AIDS Conference in Vienna, Austria, July 18-23, 2010.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
New research from the University of British Columbia and the University of Saskatchewan is adding new evidence in support of midwives as a safe option for prenatal care, especially for women who have low socioeconomic status.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205102068 | NPI | - | NPPES |
| 1952308009 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Fine-scale climate model projections suggest the possibility that population centers in cool, highland regions of East Africa could be more vulnerable to malaria than previously thought, while population centers in hot, lowland areas could be less vulnerable, according to a team of researchers. The team applied a statistical technique to conventional, coarse-scale climate models to better predict malaria dynamics at local levels.
Clinical Care Options, a leader in education for healthcare professionals, will provide official online scientific analysis of the XVIII International AIDS Conference in Vienna, Austria, July 18-23, 2010.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
New research from the University of British Columbia and the University of Saskatchewan is adding new evidence in support of midwives as a safe option for prenatal care, especially for women who have low socioeconomic status.
› Verified 8 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |